Abstract:
Objective: Metallothioneins (MT) are cytoprotective against the damaging effects of oxygen-derived free radicals. Therefore MT may be involved in defence mechanisms to counter Crohn's disease (CD) and ulcerative colitis (UC).¶Materials: 107 routinely processed tissue samples from 22 patients with CD and 48 patients with UC were tested with the monoclonal anti-MT antibody E9.¶Methods: Immunohistochemistry was used to assess MT staining in a semiquantitative manner. Chi-square test was used for statistical analysis.¶Results: MT overexpression was found in the fibroblasts of all ulcerative and/or fissural lesions in UC and CD. MT overexpression in intestinal epithelial cells of 40 % of UC and CD lesions correlated significantly with the grade of inflammation.¶Conclusions: MT-immunoreactivity in fibroblasts supports a protective role for MT in inflammatory bowel disease. It remains unclear whether MT overexpression in epithelial cells is also important in this protection.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 16 March 2000; returned for revision 2 October 2000; accepted by E. Neugebauer 7 December 2000
Rights and permissions
About this article
Cite this article
Brüwer, M., Schmid, K., Metz, K. et al. Increased expression of metallothionein in inflammatory bowel disease. Inflamm. res. 50, 289–293 (2001). https://doi.org/10.1007/PL00000246
Issue Date:
DOI: https://doi.org/10.1007/PL00000246